Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Aimovig, Alcami, altered, AMT, antibody, APOLLO, Asia, assumption, atogepant, Auxilium, Aviron, BBA, Biohaven, Bipartisan, BLA, BMI, Boulevard, built, Cadillac, California, CentreOne, chain, Charleston, chemotherapy, Chesterbrook, colorectal, comorbid, confusion, constitute, cyber, deliberate, Diego, digital, domain, domestic, donut, Duke, Elderly, Engineering, eptinezumab, erenumab, Eurasia, excise, fellow, fremanezumab, Fuqua, galcanezumab, Geoghegan, Germantown, goodwill, grow, gynecologic, halt, halted, heightened, hole, immune, inflammatory, insource, insourcing, Jonathan, KS, landlord, McPherson, MedImmune, modification, Nabriva, NC, neuropathic, neuropathy, Northeastern, obese, orthopedic, outsource, outsourcing, overhead, passed, passing, PCAOB, readout, relocation, remeasurement, resolution, rimegepant, San, Savient, saving, sc, Semprana, sophistication, stranded, suppression, thereof, tradename, tramadol, twelve, uncertainty, undertaken, unimproved, Villanova, Violin, WI, Wilmington, workforce, Wyeth
Removed:
activate, advanced, Affordability, afterload, amend, assessing, augment, blood, Calculating, cardiology, catheterization, cellular, Centocor, collection, Concert, concomitant, confirmed, Cooperation, coupled, creatinine, crystalline, curve, designing, displace, diuretic, dobutamine, Durect, dysfunction, dyspnea, ejection, electroencephalogram, elucidation, emergency, Eurasian, Explorer, facilitating, filtration, flow, fluid, footage, forcefully, founded, founder, fraction, fragile, France, function, furosemide, Germany, GFR, glomerular, goal, GPCR, implicated, intracardiac, intravascular, Italy, Johnson, Lark, leading, living, loop, Michael, Microbiology, moderate, molecular, morbidity, mortality, moving, Musculoskeletal, nitroglycerin, occupy, organism, payroll, persuade, pharmacological, Philadelphia, predicted, preload, Prize, pumped, readmission, redeemable, renin, resale, revaluation, revise, RPF, selecting, sensitivity, signal, Soergel, Spain, specificity, spectrum, stable, stimulating, suboptimal, surface, survey, systolic, transdermal, transplant, Treaty, ultimate, underwent, unique, upper, Urogenital, West
Filing tables
Filing exhibits
Related press release
Associated TRVN transcripts
TRVN similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-208538) and Forms S-8 (Nos. 333-193735, 333-195957, 333-201672, 333-208948, 333-215420, 333-215421, and 333-222471) of our report dated March 7, 2018, with respect to the financial statements of Trevena, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2017.
/s/ Ernst & Young LLP |
Philadelphia, Pennsylvania
March 7, 2018